Psycholeptics (Antipsychotics, Anxiolytics & Sedatives)
A master clinical directory of psycholeptic medications. This guide covers the pharmacology of antipsychotics, benzodiazepines, and sleep aids used to reduce mental activity and induce calm. Reviewed by Dr. Ahmad Baker for clinical safety and dependency management.
![Hyponor® [zopiclone] – Hypnotic-sedative](https://pharmacily.com/wp-content/uploads/2022/10/Insomnia-3.jpeg)
Hypnor® (Zopiclone) exhibits hypnosedative, muscle relaxant and anticonvulsant properties. Hypnor® (Zopiclone) recognizes specifically, and with high affinity, binding sites that belong to the GABA-benzodiazepine chloride channel macromolecular receptor complex.
Psychodal (risperidone) is a groundbreaking antipsychotic medication designed to address various mental health conditions. In this guide, we will explore the key components, indications for use, coping with potential side effects, suggested doses, precautions, and additional insights to empower you with comprehensive knowledge about your medication. Component Benefits Risperidone: Balancing Neurotransmitters Risperidone, the primary component…
Composition Each tablet contains: Alprazolam: 0.25 or 0.50 mg. Properties Zolam® (alprazolam) is a benzodiazepine that is used as anxiolytic, sedative, anticonvulsant and skeletal muscle relaxant. (alprazolam) produces its central anxiolytic and sedative effects via interaction with neuroreceptor site termed the gamma aminobutyric acid (GABA) benzodiazepine receptor binding. Benzodiazepine facilitates binding and action of the endogenous…
Composition Ampoule: Each ampoule (2mL) contains diazepam 10 mg. Syrup: Each teaspoonful (5mL) contains diazepam 2 mg. Tablets: Each tablet contains diazepam 2 mg or 5mg. Properties Diazepam (Valpam®) is a benzodiazepine with anticonvulsant anxiolytic, sedative, muscle relaxant, and amnestic properties. Diazepam is extensively metabolized in the liver into active metabolites such as desmethyldiazepam (nordazepam),…
Zolinda indicated for: Treatment of schizophrenia. Treatment of moderate to severe manic states in bipolar disorder type 1 and for the prevention of new manic episodes in patients who predominantly experienced manic episodes and whose previous manic episodes responded to aripiprazole treatment. Combined treatment of major depressive disorder (MDD) in patients who experienced a partial…
Arepexane indicated for: Treatment of schizophrenia. Treatment of moderate to severe manic states in bipolar disorder type 1 and for the prevention of new manic episodes in patients who predominantly experienced manic episodes and whose previous manic episodes responded to aripiprazole treatment. Combined treatment of major depressive disorder (MDD) in patients who experienced a partial…
Aripipracare indicated for: Treatment of schizophrenia. Treatment of moderate to severe manic states in bipolar disorder type 1 and for the prevention of new manic episodes in patients who predominantly experienced manic episodes and whose previous manic episodes responded to aripiprazole treatment. Combined treatment of major depressive disorder (MDD) in patients who experienced a partial…
Aripiprazole indicated for: Treatment of schizophrenia. Treatment of moderate to severe manic states in bipolar disorder type 1 and for the prevention of new manic episodes in patients who predominantly experienced manic episodes and whose previous manic episodes responded to aripiprazole treatment. Combined treatment of major depressive disorder (MDD) in patients who experienced a partial…
Aripiprex indicated for: Treatment of schizophrenia. Treatment of moderate to severe manic states in bipolar disorder type 1 and for the prevention of new manic episodes in patients who predominantly experienced manic episodes and whose previous manic episodes responded to aripiprazole treatment. Combined treatment of major depressive disorder (MDD) in patients who experienced a partial…
Prazolosab indicated for: Treatment of schizophrenia. Treatment of moderate to severe manic states in bipolar disorder type 1 and for the prevention of new manic episodes in patients who predominantly experienced manic episodes and whose previous manic episodes responded to aripiprazole treatment. Combined treatment of major depressive disorder (MDD) in patients who experienced a partial…